Oncology Collaborative

Mission Statement

The mission of the Oncology Pharmacy Collaborative is to promote the most appropriate and cost-effective, evidence-based use and administration of chemotherapy, novel therapeutic agents, and other medical treatments or supportive care to ensure the highest quality and safety standards for patients undergoing care for cancer and cancer-related diseases.

Membership

Chair: Executive Director Oncology Pharmacy Services
Co-Chair: Corporate Director of Pharmacy Operations
Members: Senior Vice President and Chief Pharmacy Officer, Corporate Assistant Director of Clinical Pharmacy Services, IV Room Supervisors and Oncology Pharmacists from the Acute Care Service Line

View the Oncology Collaborative Membership

Meetings

The Oncology Collaborative shall meet quarterly or as otherwise deemed necessary by the chair.

How We Accomplish Our Mission

The Oncology Pharmacy Collaborative is a subcommittee of the Oncology P&T Committee and the Director’s Council. The Collaborative assists the Rutgers Cancer Institute/RWJBarnabas Health enterprise by evaluating the quality and safety of the delivery of pharmaceutical care to patients with the diagnosis of cancer or cancer related diseases. It is a single-disciplinary committee that is responsible for the assigned process of medication formulary review and contributing to the development of policies, procedures, and guidelines for medication management of cancer-related therapies within Rutgers Cancer Institute and RWJBarnabas. All functions are directed by and reported back to the main the Oncology P&T Committee and the Director’s Council.